Submission Details
| 510(k) Number | K781121 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 03, 1978 |
| Decision Date | August 14, 1978 |
| Days to Decision | 42 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | — |
K781121 is an FDA 510(k) clearance for the HEMOLYSE, a Products, Red-cell Lysing Products (Class I — General Controls, product code GGK), submitted by Electrophoresis Corp. of America (Mchenry, US). The FDA issued a Cleared decision on August 14, 1978, 42 days after receiving the submission on July 3, 1978. This device falls under the Hematology review panel. Regulated under 21 CFR 864.8540.
| 510(k) Number | K781121 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 03, 1978 |
| Decision Date | August 14, 1978 |
| Days to Decision | 42 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | — |
| Product Code | GGK — Products, Red-cell Lysing Products |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 864.8540 |